Nicholas Hoffman & Company LLC. grew its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 37.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,211 shares of the biopharmaceutical company’s stock after buying an additional 12,063 shares during […]
Cantor Fitzgerald restated their overweight rating on shares of Pfizer (NYSE:PFE – Free Report) in a research note released on Monday, Benzinga reports. The brokerage currently has a $45.00 price target on the biopharmaceutical company’s stock. A number of other equities research analysts have also recently weighed in on PFE. Guggenheim assumed coverage on shares […]
Zhang Financial LLC trimmed its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 4.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 71,535 shares of the biopharmaceutical company’s stock after selling 3,648 shares during the period. […]
Zhang Financial LLC decreased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 4.9% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 71,535 shares of the biopharmaceutical company’s stock after selling 3,648 shares during the period. Zhang Financial LLC’s holdings in Pfizer were worth $2,059,000 at the end of the […]
Cerity Partners LLC increased its position in Pfizer Inc. (NYSE:PFE – Free Report) by 19.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,471,344 shares of the biopharmaceutical company’s stock after purchasing an additional 238,611 shares during the period. […]